Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
MBLX's Cash to Debt is ranked higher than
99% of the 1067 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.98 vs. MBLX: No Debt )
Ranked among companies with meaningful Cash to Debt only.
MBLX' s Cash to Debt Range Over the Past 10 Years
Min: 9.28  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.68
MBLX's Equity to Asset is ranked higher than
69% of the 1029 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.54 vs. MBLX: 0.68 )
Ranked among companies with meaningful Equity to Asset only.
MBLX' s Equity to Asset Range Over the Past 10 Years
Min: -6.36  Med: 0.69 Max: 0.95
Current: 0.68
-6.36
0.95
Interest Coverage No Debt
MBLX's Interest Coverage is ranked higher than
99% of the 744 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 15.94 vs. MBLX: No Debt )
Ranked among companies with meaningful Interest Coverage only.
MBLX' s Interest Coverage Range Over the Past 10 Years
Min: 9999.99  Med: 10000.00 Max: 9999.99
Current: No Debt
F-Score: 4
Z-Score: -46.66
M-Score: -2.69
WACC vs ROIC
36.43%
-4245.91%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -930.41
MBLX's Operating margin (%) is ranked lower than
99% of the 1047 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.31 vs. MBLX: -930.41 )
Ranked among companies with meaningful Operating margin (%) only.
MBLX' s Operating margin (%) Range Over the Past 10 Years
Min: -8691.74  Med: -1483.73 Max: 8.51
Current: -930.41
-8691.74
8.51
Net-margin (%) -927.44
MBLX's Net-margin (%) is ranked lower than
99% of the 1051 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.59 vs. MBLX: -927.44 )
Ranked among companies with meaningful Net-margin (%) only.
MBLX' s Net-margin (%) Range Over the Past 10 Years
Min: -8661.38  Med: -1355.53 Max: 8.58
Current: -927.44
-8661.38
8.58
ROE (%) -163.83
MBLX's ROE (%) is ranked lower than
99% of the 1030 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 7.91 vs. MBLX: -163.83 )
Ranked among companies with meaningful ROE (%) only.
MBLX' s ROE (%) Range Over the Past 10 Years
Min: -150.71  Med: -78.29 Max: 8.36
Current: -163.83
-150.71
8.36
ROA (%) -130.27
MBLX's ROA (%) is ranked lower than
99% of the 1070 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.88 vs. MBLX: -130.27 )
Ranked among companies with meaningful ROA (%) only.
MBLX' s ROA (%) Range Over the Past 10 Years
Min: -118.44  Med: -43.13 Max: 5.32
Current: -130.27
-118.44
5.32
ROC (Joel Greenblatt) (%) -2751.80
MBLX's ROC (Joel Greenblatt) (%) is ranked lower than
99% of the 1060 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.36 vs. MBLX: -2751.80 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MBLX' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4296.08  Med: -1109.34 Max: 198.29
Current: -2751.8
-4296.08
198.29
Revenue Growth (3Y)(%) -75.90
MBLX's Revenue Growth (3Y)(%) is ranked lower than
99% of the 930 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.00 vs. MBLX: -75.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MBLX' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -75.9  Med: -12.40 Max: 172.8
Current: -75.9
-75.9
172.8
» MBLX's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-12)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

MBLX Guru Trades in

MBLX Guru Trades in

Q2 2014

MBLX Guru Trades in Q2 2014

Jim Simons 56,507 sh (+8.88%)
» More
Q3 2014

MBLX Guru Trades in Q3 2014

Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with MBLX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:ROCO:1787, XKRX:045060, TSE:4635, BOM:526247, XPAR:ALCRB, OTCPK:DTRX » details
Traded in other countries:M6X1.Germany,
Metabolix Inc is a bioscience company that provides environmentally friendly solutions to the plastics, chemicals & energy industries. It has capabilities in microbial genetics, fermentation process engineering, chemical engineering, etc.

Metabolix Inc was incorporated in Massachusetts in June 1992 under the name Metabolix, Inc. In September 1998, it reincorporated in Delaware. The Company is an innovation-driven bioscience company focused on delivering sustainable solutions to the plastics and chemicals industries. It is engaged in products and markets development of a biopolymer platform, based on technology developed by the Company and early commercialization efforts conducted through the Telles joint venture with ADM. The Company has its operations in U.S. and Canada. It has core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science, and has assembled these capabilities in a way that has allowed the Company to integrate its biotechnology research with real world chemical engineering and industrial practice. It has created an intellectual property portfolio to protect its innovations and, together with its technology, to serve as a valuable foundation for future industry collaborations. It has focused on a family of biopolymers found in nature called polyhydroxyalkanoates "PHA", which occur naturally in living organisms and are chemically similar to polyesters. It has demonstrated the production of PHAs at industrial scale to produce PHA biopolymers and PHA precursors to biobased industrial chemicals. It has also demonstrated the production of polyhydroxybutyrate, a subclass of PHAs, in agriculturally significant non-food crops. Polymers are found in nature in a range of organisms including microbes, plants and animals. The Company competes with Dow Chemical, DuPont, BASF, Ineos, LyondellBasell, SABIC, Mitsubishi Chemical, DuPont, DSM, Arkema and Braskem. The Company is subject to significant foreign and domestic government regulations, and compliance or failure to comply with these regulations could harm its business.

Ratios

vs
industry
vs
history
P/B 3.10
MBLX's P/B is ranked lower than
74% of the 1050 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.59 vs. MBLX: 3.10 )
Ranked among companies with meaningful P/B only.
MBLX' s P/B Range Over the Past 10 Years
Min: 0.69  Med: 3.49 Max: 18.59
Current: 3.1
0.69
18.59
P/S 7.83
MBLX's P/S is ranked lower than
92% of the 1062 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.03 vs. MBLX: 7.83 )
Ranked among companies with meaningful P/S only.
MBLX' s P/S Range Over the Past 10 Years
Min: 0.94  Med: 57.57 Max: 730.2
Current: 7.83
0.94
730.2
Current Ratio 2.61
MBLX's Current Ratio is ranked higher than
73% of the 925 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.75 vs. MBLX: 2.61 )
Ranked among companies with meaningful Current Ratio only.
MBLX' s Current Ratio Range Over the Past 10 Years
Min: 1.43  Med: 10.90 Max: 38.31
Current: 2.61
1.43
38.31
Quick Ratio 2.48
MBLX's Quick Ratio is ranked higher than
79% of the 925 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.28 vs. MBLX: 2.48 )
Ranked among companies with meaningful Quick Ratio only.
MBLX' s Quick Ratio Range Over the Past 10 Years
Min: 1.43  Med: 10.27 Max: 38.31
Current: 2.48
1.43
38.31
Days Inventory 242.28
MBLX's Days Inventory is ranked lower than
96% of the 1007 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 67.04 vs. MBLX: 242.28 )
Ranked among companies with meaningful Days Inventory only.
MBLX' s Days Inventory Range Over the Past 10 Years
Min: 266.84  Med: 308.91 Max: 410.05
Current: 242.28
266.84
410.05
Days Sales Outstanding 37.84
MBLX's Days Sales Outstanding is ranked higher than
77% of the 846 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 58.71 vs. MBLX: 37.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
MBLX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.87  Med: 35.41 Max: 681.12
Current: 37.84
4.87
681.12
Days Payable 95.33
MBLX's Days Payable is ranked higher than
83% of the 897 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 47.82 vs. MBLX: 95.33 )
Ranked among companies with meaningful Days Payable only.
MBLX' s Days Payable Range Over the Past 10 Years
Min: 3.68  Med: 39.53 Max: 315.6
Current: 95.33
3.68
315.6

Valuation & Return

vs
industry
vs
history
Price/Net Cash 11.57
MBLX's Price/Net Cash is ranked higher than
52% of the 141 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.45 vs. MBLX: 11.57 )
Ranked among companies with meaningful Price/Net Cash only.
MBLX' s Price/Net Cash Range Over the Past 10 Years
Min: 1.35  Med: 5.13 Max: 30.71
Current: 11.57
1.35
30.71
Price/Net Current Asset Value 4.76
MBLX's Price/Net Current Asset Value is ranked higher than
55% of the 475 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.45 vs. MBLX: 4.76 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MBLX' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.19  Med: 4.28 Max: 23.53
Current: 4.76
1.19
23.53
Price/Tangible Book 3.12
MBLX's Price/Tangible Book is ranked lower than
70% of the 1003 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.63 vs. MBLX: 3.12 )
Ranked among companies with meaningful Price/Tangible Book only.
MBLX' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.01  Med: 3.65 Max: 18.27
Current: 3.12
1.01
18.27
Price/Median PS Value 0.14
MBLX's Price/Median PS Value is ranked higher than
99% of the 1029 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.13 vs. MBLX: 0.14 )
Ranked among companies with meaningful Price/Median PS Value only.
MBLX' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.02  Med: 1.17 Max: 12.68
Current: 0.14
0.02
12.68
Earnings Yield (Greenblatt) (%) -141.35
MBLX's Earnings Yield (Greenblatt) (%) is ranked lower than
99% of the 1098 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.70 vs. MBLX: -141.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MBLX' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -141.35  Med: 42.00 Max: 2699
Current: -141.35
-141.35
2699

More Statistics

Revenue (TTM) (Mil) $2.62
EPS (TTM) $ -0.94
Beta4.61
Short Percentage of Float9.08%
52-Week Range $0.63 - 4.76
Shares Outstanding (Mil)27.73
» More Articles for MBLX

Headlines

Articles On GuruFocus.com
5 Biggest Losers of Magic Formula Investing in 2013 Dec 18 2013 
METABOLIX, INC. Reports Operating Results (10-K) Mar 10 2011 
Market Neutral Trade for 2.10.2011: Long EMN, Short MBLX Feb 10 2011 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 09 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Jul 29 2010 
METABOLIX, INC. Reports Operating Results (10-Q) May 03 2010 
METABOLIX, INC. Reports Operating Results (10-Q) Nov 03 2009 
METABOLIX, INC. Reports Operating Results (10-Q) Aug 06 2009 
METABOLIX, INC. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
METABOLIX, INC. Financials May 24 2016
METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of... May 19 2016
Metabolix Raises $2 Million in Amendment to Licensing Deal with Tepha May 18 2016
Metabolix Raises $2 Million in Amendment to Licensing Deal with Tepha May 18 2016
METABOLIX, INC. Files SEC form 10-Q, Quarterly Report May 16 2016
Metabolix Evaluating Strategic Alternatives for its Specialty PHA Biopolymers Business and Yield10... May 16 2016
Metabolix Evaluating Strategic Alternatives for its Specialty PHA Biopolymers Business and Yield10... May 16 2016
Metabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016 Apr 07 2016
Metabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016 Apr 07 2016
Edited Transcript of MBLX earnings conference call or presentation 29-Mar-16 8:30pm GMT Mar 30 2016
Metabolix Signs MOU with CJ CheilJedang for Strategic Commercial Manufacturing Arrangement Mar 29 2016
Metabolix Announces Fourth Quarter and Full Year 2015 Financial Results Mar 29 2016
METABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... Mar 29 2016
Metabolix Announces Fourth Quarter and Full Year 2015 Financial Results Mar 29 2016
Metabolix Signs MOU with CJ CheilJedang for Strategic Commercial Manufacturing Arrangement Mar 29 2016
Q4 2015 Metabolix Inc Earnings Release - After Market Close Mar 29 2016
Metabolix to Conduct Webcast of Its Fourth Quarter 2015 Earnings Call Mar 22 2016
Metabolix to Conduct Webcast of Its Fourth Quarter 2015 Earnings Call Mar 22 2016
Metabolix to Highlight Use of Mirel PHA Biopolymers as Performance Modifiers in PLA Applications at... Mar 22 2016
Metabolix to Highlight Use of Mirel PHA Biopolymers as Performance Modifiers in PLA Applications at... Mar 22 2016
Metabolix to Present at 28th Annual ROTH Conference Mar 10 2016
Metabolix to Relocate Corporate Headquarters to Woburn, Massachusetts in 2016 Jan 26 2016
METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jan 26 2016
Metabolix, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 16 2015
What's Driving the Price Movement - Research on HMN Financial, Metabolix, Brainstorm Cell... Dec 04 2015
METABOLIX, INC. Files SEC form 10-Q, Quarterly Report Nov 12 2015
Metabolix Announces Third Quarter 2015 Financial Results Nov 10 2015
METABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 10 2015
Metabolix to Conduct Webcast of Its Third Quarter 2015 Earnings Call Oct 27 2015
Metabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration Oct 15 2015
METABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Oct 07 2015
Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC Oct 07 2015
Metabolix to Present New Findings on Multifunctional Benefits of PHA Biopolymers in PVC Applications Oct 06 2015
Metabolix, Inc. Earnings Q2, 2015 Oct 02 2015
METABOLIX, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Sep 17 2015
CORRECTING and REPLACING -- Metabolix Launches Yield10 Bioscience to Develop and Commercialize... Sep 17 2015
Metabolix Launches Yield10 Bioscience to Develop and Commercialize Innovations in Crop Science Sep 17 2015
Metabolix Announces Second Quarter 2015 Financial Results Aug 12 2015
Metabolix to Conduct Webcast of Its Second Quarter 2015 Earnings Call Aug 03 2015
Metabolix, Inc. Announces $15 Million Equity Private Placement Jun 16 2015
Metabolix to Exhibit Innovations in Building Materials at Profiles 2015 Jun 08 2015
Metabolix to Present Sustainability Innovations in Personal Care Products and Packaging at HBA... Jun 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)